By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

A sleep study can show how severe sleep apnea is and help determine the best course of treatment. People can discuss the potential benefits and risks of a mouthguard with their doctor. If they opt ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...

“They also have increased prevalence of sleep apnea, hence evaluating markers of brain health such as the one mentioned serve as a way to understand early markers of disease risk for Alzheimer ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

The Food and Drug Administration on Friday approved the weight-loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.